Position in TMO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,236,342
-$4,783,384 QoQ
Shares Held
16,428
-48.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#696
of 2,602 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Entropy Technologies, LP holds $40,702,104 across 17 Diagnostics & Research names. TMO ranks #2 (20.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
23,854 | $12,557,699 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
16,428 | $8,236,342 | |
| 3 | DHR |
Danaher Corp /De/
|
27,385 | $5,216,294 | |
| 4 | NTRA |
Natera, Inc.
|
13,559 | $3,680,590 | |
| 5 | A |
Agilent Technologies, Inc.
|
14,321 | $1,902,258 | |
| 6 | QGEN |
Qiagen N.V.
|
44,810 | $1,752,071 | |
| 7 | ILMN |
Illumina, Inc.
|
7,726 | $1,358,462 | |
| 8 | DGX |
Quest Diagnostics Inc
|
5,779 | $1,224,859 |
All Filings in TMO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,236,342 | 16,428 | Shares | Sole | 2026-08-13 | |
| 2025-06-30 | $13,019,726 | 32,111 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $4,248,198 | 8,166 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $10,218,157 | 16,519 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $4,327,778 | 7,826 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,126,009 | 7,099 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,590,785 | 4,881 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||